Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
1376
DELISTED
PROS Holdings
PRO
| $683K | 0.01% |
+28,146
| New | +$690K |
|
1377
Accel Entertainment
ACEL
$972M
| $681K | 0.01% |
88,459
-63,643
| -42% | -$546K |
|
1378
Metallus
MTUS
$776M
| $681K | 0.01% |
37,498
+2,347
| +7% | +$41.6K |
|
1379
CALL
Old Dominion Freight Line
ODFL
$41.8B
| $680K | 0.01% |
4,800
+1,200
| +33% | +$170K |
|
1380
Customers Bancorp
CUBI
$2.67B
| $679K | 0.01% |
23,970
-18,716
| -44% | -$583K |
|
1381
CALL
Intercontinental Exchange
ICE
$91.5B
| $678K | 0.01% |
+6,600
| New | +$657K |
|
1382
Peloton Interactive
PTON
$2.35B
| $678K | 0.01% |
+85,330
| New | +$819K |
|
1383
CALL
SL Green Realty
SLG
$4.15B
| $678K | 0.01% |
20,100
+10,500
| +109% | +$399K |
|
|
SLAM
1384
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $678K | 0.01% |
67,039
| – | – |
|
1385
Twist Bioscience
TWST
$8.83B
| $677K | 0.01% |
28,425
+16,626
| +141% | +$482K |
|
1386
Sonos
SONO
$1.82B
| $676K | 0.01% |
+40,003
| New | +$651K |
|
1387
Definitive Healthcare
DH
$77M
| $675K | 0.01% |
+61,451
| New | +$790K |
|
1388
CALL
SLB Ltd
SLB
$80.1B
| $674K | 0.01% |
+12,600
| New | +$627K |
|
1389
Ducommun
DCO
$2.78B
| $673K | 0.01% |
13,470
+5,517
| +69% | +$263K |
|
1390
Olin
OLN
$2B
| $672K | 0.01% |
12,701
-24,536
| -66% | -$1.3M |
|
1391
CALL
SBA Communications
SBAC
$19.6B
| $672K | 0.01% |
+2,400
| New | +$668K |
|
|
1392
PUT
SBA Communications
SBAC
$19.6B
| $672K | 0.01% |
+2,400
| New | +$668K |
|
1393
CALL
Canadian Pacific Kansas City
CP
$83.2B
| $671K | 0.01% |
9,000
+700
| +8% | +$52.7K |
|
1394
Newmont
NEM
$139B
| $671K | 0.01% |
+14,215
| New | +$635K |
|
|
RGF
1395
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $671K | 0.01% |
8,440
-3,616
| -30% | -$295K |
|
1396
PUT
Cleveland-Cliffs
CLF
$6.45B
| $670K | 0.01% |
41,500
+1,500
| +4% | +$22.6K |
|
1397
PUT
Bunge Global
BG
$21.2B
| $669K | 0.01% |
6,700
+1,100
| +20% | +$106K |
|
1398
National Grid
NGG
$80.9B
| $669K | 0.01% |
11,778
-17,647
| -60% | -$943K |
|
1399
CALL
New York Times
NYT
$10.9B
| $668K | 0.01% |
+20,600
| New | +$671K |
|
|
FOLD
1400
DELISTED
Amicus Therapeutics
FOLD
| $666K | 0.01% |
+54,577
| New | +$614K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.